| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3209107 | Journal of the American Academy of Dermatology | 2009 | 9 Pages |
Abstract
Topical bexarotene 1% application is well tolerated and possibly effective. A randomized placebo-controlled trial should be conducted.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Rakhshandra MD, Jenny MD, Roland MS, Victor PhD, Madeleine MD,